8-K: Climb Bio Stockholders Elect Directors and Ratify Auditor at 2025 Annual Meeting

Climb Bio, Inc. announced the successful election of two directors, Judith Dunn, Ph.D. and Stephen Thomas, Ph.D., and the ratification of PricewaterhouseCoopers LLP as its independent auditor at its 2025 Annual Meeting of Stockholders.

Summary

• Climb Bio, Inc. held its 2025 Annual Meeting of Stockholders on June 4, 2025.
• Stockholders elected Judith Dunn, Ph.D., to the Company's board of directors for a three-year term expiring at the 2028 annual meeting, with 36,827,909 votes For, 6,615,228 votes Withheld, and 10,126,633 Broker Non-Votes.
• Stockholders elected Stephen Thomas, Ph.D., to the Company's board of directors for a three-year term expiring at the 2028 annual meeting, with 41,359,959 votes For, 2,083,178 votes Withheld, and 10,126,633 Broker Non-Votes.
• Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, with 53,442,396 votes For, 8,780 votes Against, and 118,594 Abstentions.

Sentiment

Score: 7

Explanation: The document reports on routine and successful corporate governance matters, including the election of directors and ratification of the auditor, with strong shareholder approval, indicating stability and proper functioning of the company's governance.

Positives

• The successful election of both director nominees indicates strong shareholder support for the proposed board composition.
• The overwhelming ratification of PricewaterhouseCoopers LLP as the independent auditor demonstrates shareholder confidence in the company's financial oversight and reporting processes.

Industry Context

This filing is a routine corporate governance update, common across all industries, indicating standard operational procedures for a publicly traded company. It does not provide specific industry-related insights or trends.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The election of directors and ratification of the auditor directly impacts shareholder representation and the integrity of financial reporting.
• Employees: Stable corporate governance provides a clear leadership structure and strategic direction.

Next Steps

• Judith Dunn, Ph.D., and Stephen Thomas, Ph.D., will serve three-year terms on the board of directors, expiring at the 2028 annual meeting of stockholders.
• PricewaterhouseCoopers LLP will serve as the independent registered public accounting firm for Climb Bio, Inc. for the fiscal year ending December 31, 2025.

Key Dates

Recommendation

Keywords

Climb Bio, Annual Meeting, Stockholders, Director Election, Auditor Ratification, Corporate Governance, SEC Filing, 8-K, Biotechnology